Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

NCT05437211

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Centre de Reference Hemophilie Unite D'Hemostase Clinique Bron, Auvergne-Rhône-Alpes, France
  • CHU Estaing Clermont-Ferrand, Auvergne-Rhône-Alpes, France
  • Hôpital de Hautepierre - Pôle MIRMED Strasbourg, Grand Est, France
  • CHU Purpan Toulouse, Haute-Garonne, France
View Trial Details
Completed

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02303821

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • University of California San Francisco Benioff Childrens Hospital Oakland Oakland, California, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Healthcare of Atlanta, Egleston Atlanta, Georgia, United States
View all 122 locations
View Trial Details
Completed

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

NCT04691648

Conditions
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Site KR82013 Wŏnju, Gangwon-do, South Korea
  • Site KR82006 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82003 Jeollanam-do, Hwasun-gun, South Korea
  • Site KR82011 Busan, South Korea
View Trial Details

Related conditions